First Sponsor Group Limited (SGX:ADN)

Market Cap	1.19B
Revenue (ttm)	298.58M
Net Income (ttm)	94.20M
Shares Out	1.13B
EPS (ttm)	0.08
PE Ratio	12.59
Forward PE	n/a
Dividend	0.05 (4.43%)
Ex-Dividend Date	Aug 15, 2025

Volume	10,500
Average Volume	6,255
Open	1.040
Previous Close	1.040
Day's Range	1.040 - 1.050
52-Week Range	1.000 - 1.100
Beta	0.07
RSI	53.05
Earnings Date	Jul 25, 2025

About Blueprint Medicines

First Sponsor Group Limited, an investment holding company, invests in, develops, and sells residential and commercial properties in the People’s Republic of China, Europe, and internationally. The company operates through Property Development, Property Investment, Property Financing, and Hotel Operations segments. It provides interest-bearing loans to associates, joint ventures, and third parties. In addition, the company engages in the subscription of debt securities and vendor financing arrangements, as well as manufacturing, trading, and di...

• Industry: Land Subdividers and Developers, Except Cemeteries
• Founded: 2007
• Employees: 513
• Stock Exchange: Singapore Exchange
• Ticker Symbol: ADN

Financial Performance

In 2024, First Sponsor Group's revenue was 317.56 million, an increase of 12.24% compared to the previous year's 282.93 million. Earnings were 93.02 million, an increase of 642.83%.